Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
INmune Bio, Inc. (INMB) had Return on Tangible Equity of -22.38% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-5.26M |
|
-- |
|
-- |
|
$5.47M |
|
$-5.47M |
|
$0.21M |
|
$-5.26M |
|
$-5.26M |
|
$-5.26M |
|
$-5.26M |
|
$-5.26M |
|
$-5.26M |
|
$-5.47M |
|
$-5.42M |
|
24.76M |
|
24.76M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$29.89M |
|
$0.95M |
|
$2.46M |
|
$32.35M |
|
$8.42M |
|
-- |
|
$0.41M |
|
$8.83M |
|
$23.52M |
|
$23.52M |
|
$23.52M |
|
26.59M |
|
| Cash Flow Statement Financials | |
$-22.58M |
|
$-1.04M |
|
$27.61M |
|
$20.92M |
|
$24.75M |
|
$3.83M |
|
$9.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.55 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.62M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-22.38% |
|
|
Return on Tangible Equity |
-22.38% |
-16.27% |
|
-22.38% |
|
$0.88 |
|
$-0.95 |
|
$-0.91 |
|